Le Katherine Y, Dastgheyb Sana, Ho Trung V, Otto Michael
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, MD, USA ; Division of Hospital Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine Rochester, MN, USA.
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, MD, USA ; Department of Orthopedic Surgery, Thomas Jefferson University School of Medicine Philadelphia, PA, USA.
Front Cell Infect Microbiol. 2014 Nov 26;4:167. doi: 10.3389/fcimb.2014.00167. eCollection 2014.
Staphylococci are frequently implicated in human infections, and continue to pose a therapeutic dilemma due to their ability to form deeply seated microbial communities, known as biofilms, on the surfaces of implanted medical devices and host tissues. Biofilm development has been proposed to occur in three stages: (1) attachment, (2) proliferation/structuring, and (3) detachment/dispersal. Although research within the last several decades has implicated multiple molecules in the roles as effectors of staphylococcal biofilm proliferation/structuring and detachment/dispersal, to date, only phenol soluble modulins (PSMs) have been consistently demonstrated to serve in this role under both in vitro and in vivo settings. PSMs are regulated directly through a density-dependent manner by the accessory gene regulator (Agr) system. They disrupt the non-covalent forces holding the biofilm extracellular matrix together, which is necessary for the formation of channels, a process essential for the delivery of nutrients to deeper biofilm layers, and for dispersal/dissemination of clusters of biofilm to distal organs in acute infection. Given their relevance in both acute and chronic biofilm-associated infections, the Agr system and the psm genes hold promise as potential therapeutic targets.
葡萄球菌常引发人类感染,并且由于其能够在植入式医疗设备和宿主组织表面形成深层微生物群落(即生物膜),从而持续构成治疗难题。生物膜的形成过程被认为分为三个阶段:(1)附着,(2)增殖/结构化,以及(3)脱离/扩散。尽管在过去几十年的研究中发现多种分子在葡萄球菌生物膜增殖/结构化及脱离/扩散过程中发挥效应分子的作用,但迄今为止,只有酚溶性调节蛋白(PSM)在体外和体内环境下均被一致证明发挥此作用。PSM由辅助基因调节子(Agr)系统直接通过密度依赖性方式进行调控。它们破坏维持生物膜细胞外基质在一起的非共价力,而这对于形成通道是必要的,通道形成过程对于将营养物质输送到生物膜更深层以及在急性感染中将生物膜簇扩散/传播到远端器官至关重要。鉴于它们在急性和慢性生物膜相关感染中的相关性,Agr系统和psm基因有望成为潜在的治疗靶点。